Skip to content

NGNE

Neurogene Inc.

NASDAQ · USHealthcareBiotechnology
$37.34+0.08%

Price as of Jul 20, 2026

NGNE analysis

Neurogene Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for NGNE is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research